Download Brochure
Table of Content
Get a Price
March 2025
Principal Consultant
Reviewed By
The global advanced wound care market size is calculated at US$ 11.28 in 2024, grew to US$ 11.82 billion in 2025, and is projected to reach around US$ 18.04 billion by 2034. The market is expanding at a CAGR of 4.81% between 2025 and 2034. Increasing surgical procedures are driving the growth of the advanced wound care market.
The advanced wound care market deals with developing wound care products, techniques, and other aspects associated with advanced wound care. Following the failure of routine wound care, advanced wound care therapies are employed as interventions. Although the efficiency, comparative effectiveness, and damage of the numerous and expanding advanced wound care treatments of various compositions and indications have not been thoroughly demonstrated, they have been produced. The advanced wound care industry is experiencing a surge in developments in wound care. Skin replacements, antimicrobial dressings, negative pressure wound therapy, bioactive wound dressings, and stem cell therapy are a few of the cutting-edge items that have recently entered the wound care market.
Additionally, AI categories may be used at different phases of wound care to enhance measurement, categorization, and diagnosis. AI has applications in wound healing, including the ability to read electronic medical records (EMR), evaluate pictures, and forecast clinical results. By evaluating wounds for indications of infection, necrosis, or healing, AI also helps with wound care. AI has also helped develop better prognoses, preventative measures, and more individualized care. Healthcare practitioners may use AI to significantly advance the area of advanced wound care provided the right precautions are taken and a cautiously hopeful approach is taken.
Rising Cases of Diabetic Foot Ulcers
Diabetes has a huge impact on healthcare systems. A serious epidemic is diabetes mellitus. By 2045, around 700 million individuals will have diabetes, according to the International Diabetes Federation. In 2021, Turkey had the greatest number of adults with diabetes in Europe, with 9 million; by 2045, that figure is expected to rise to 13.4 million, according to the International Diabetes Federation. One-third of the world's half a billion diabetics are estimated to get a diabetic foot ulcer at some point in their lives; over half of these ulcers will get infected, and 17% will result in amputation.
Regulatory Challenges
Fresh wound care product regulatory clearance processes can be expensive and time-consuming. Regional regulatory restrictions may cause delays in product availability and market penetration. Moreover, a lack of knowledge in the uncharted areas may reduce the use of these goods, technologies, and therapies.
Technological Advancements in Advanced Wound Care
Chronic wounds need specialized, extensive biomedical treatment to be managed since they have a negative impact on patients' quality of life, increase morbidity and mortality, and place a significant financial strain on healthcare systems across the world. Smart dressings, nanotherapeutics, stem cell treatment, bioengineered skin grafts, and 3D bioprinting-based approaches to enhance therapeutic results with an emphasis on skin regeneration with negligible side effects are recent advancements in advanced wound care technologies, which is promoting the growth of the advanced wound care market.
By product, the moist wound care segment led the advanced wound care market in 2024. A wet atmosphere speeds up the healing of wounds. Furthermore, there are additional advantages to the wet environment that promote wound healing and reduce scarring. Additionally, the moist atmosphere is advantageous for tissue and cell transplantation as well as a variety of topical therapies. As a result, moist wound dressings are essential for treating both acute and chronic wounds.
By product, the active wound care segment is estimated to be the fastest-growing in the advanced wound care market during the predicted timeframe. A variety of cutting-edge technology and solutions are used in active wound care to help people with acute or chronic wounds heal more quickly and achieve better results. Innovative treatments, including tissue-engineered skin replacements, growth factor therapy, and bioengineered dressings, are all part of this developing industry.
By application, the chronic wounds segment held the major share of the advanced wound care market in 2024. Because different types of wounds undergo different biochemical and cellular processes, wound healing—especially chronic wounds—presents significant challenges. The understanding of therapeutic and diagnostic methods to wound healing has been greatly improved by recent technological developments. Traditional textile dressings have given way to a range of cutting-edge substitutes in the advancement of wound treatment. The customisation of wound healing is facilitated by technological innovations like electronic skin (e-skin) therapy and 3D printing.
By application, the acute wound segment is expected to grow at the fastest CAGR in the advanced wound care market during 2025-2034. Acute wounds, which can heal in the anticipated amount of time, are more frequent in daily life and are brought on by cuts, scratches, surgeries, or trauma. Emergency care clinicians need to be up to date on acute wound treatment since millions of ED visits include wound care each year. The location and features of the wound determine the acute wound care. Although there isn't a single method that works for all wounds, the foundation for outstanding wound care is provided by a methodical approach to acute wound care combined with contemporary best practices.
By end-use, the hospital segment was dominant in the advanced wound care market in 2024. The implementation of best practices for wound care has received great support from hospitals. Wound care professionals deal with a variety of wounds in the hectic setting of hospital acute care, including acute traumatic injuries and surgical incisions. In order to promote a cooperative approach to patient care, this environment provides the chance to collaborate closely with a multidisciplinary team that includes surgeons, nurses, and physical therapists.
By end-use, the home healthcare segment is expected to grow at the fastest rate in the advanced wound care market in the coming years. Every innovative wound care therapy is customized for each patient and carried out in their home, leading to better results, a higher quality of life, and less stress. Both the cost of traveling and the expenditure of missing in-clinic visits are eliminated. Every patient has easy access to direct treatment from their own physician assistant, patient care coordinator, and supervision provider. Overall satisfaction, value, and compliance are increased as a result.
North America dominated the advanced wound care market share by 46% in 2024 due to the increasing number of chronic wound patients annually, widespread use of innovative wound care devices for managing chronic wounds, and advantageous reimbursement. All of the major market players are well-represented in North America, and a lot of research is being done on wound healing technologies, which is still a major factor in the industry's expansion.
Among Americans of all ages, 98 million persons are at high risk for diabetes, and over 38 million have the disease. The annual cost of direct medical expenses is $307 billion, while lost productivity costs an additional $106 billion. In the US, diabetic foot ulcers affect over 1.6 million individuals annually. 80% of amputations of the lower extremities are preceded by these ulcers. An estimated $9 billion to $13 billion is spent on treating diabetic foot ulcers in the US each year.
|
Canadian Province
|
Cost of Wound Care (As Per Data Publish in 2024)
|
|
|
Yukon
|
$25 Million
|
|
|
N. West Terr
|
$34 Million
|
|
|
British Columbia
|
$1.8 Billion
|
|
|
Alberta
|
$1.5 Billion
|
|
|
Nunavut
|
$33.8 Million
|
|
|
Manitoba
|
$442 Million
|
|
|
Saskatchewan
|
$389 Million
|
|
|
Quebec
|
$2.7 Billion
|
|
|
Ontario
|
$4.5 Billion
|
|
|
Pei
|
$55.6 Million
|
|
|
New Brunswick
|
$248 Million
|
|
|
Newfoundland
|
$195 Million
|
|
|
Nova Scotia
|
$363 Million
|
|
In Canada, up to 25% of diabetics will develop foot ulcers at some point in their lives. In Canada, non-traumatic lower limb amputations are more than 20 times more common in persons with diabetes than in the general population, with foot ulcers being the first complication in 85% of cases. In order to enable Diabetes Canada to start putting the objectives and recommendations included in the Framework for Diabetes in Canada into practice, the Federal Government announced in June 2023 that it would provide almost $1 million over three years.
Asia Pacific is estimated to host the fastest-growing advanced wound care market during the forecast period. This is a result of rising healthcare costs per person. Furthermore, market participants in this area spend heavily, which will increase demand for cutting-edge wound care products. The usage of these products is also anticipated to increase as a result of growing government initiatives to increase knowledge of appropriate wound treatment.
China's healthcare system is beginning to feel the impact of the increasing diabetes burden resulting from the country's rapid economic transformation and urbanization. With the goal of reaching every region of China, the initiative is a nationwide wound treatment program. In order to cover as many topics as feasible over the course of the three years, training will be conducted annually at five different hospitals. This initial study, focusing on diabetic foot ulcers, is being conducted in China by the Chinese Tissue Repair Society (CTRS) with the assistance of Coloplast A/S and the World Diabetes Foundation. With the goal of reaching every region of China, the initiative is a nationwide wound treatment program. In order to cover as many topics as feasible over the course of the three years, training will be conducted annually at five different hospitals.
With 69.2 million persons with diabetes (PWD) in 2015, an 8.8% prevalence rate, and an estimated 123.5 million cases in 2040, India is quickly becoming the global center for diabetes. About 25% of PWDs in India had a DFU diagnosis, according to a systematic study. Of those, 20% required amputation, and 50% needed hospitalization because of further infections. According to a senior government official, India intends to provide incentives in 2026 to encourage the domestic production of GLP-1 medications, which are used to treat obesity and diabetes.
Europe is expected to be significantly growing in the advanced wound care market during the forecast period, driven by a growing number of wound patients, an aging population, and government assistance for efficient wound care. The major nations with the largest market shares in Europe are France, Germany, and the United Kingdom. The use of NPWT, bioengineered materials, and antimicrobial dressings as best practices in wound care is becoming more and more popular.
One of the most prevalent conditions in Germany is diabetes mellitus (DM), which contributes to significant medical expenses and is linked to up to 75% of all lower limb amputations performed in the country. Approximately 8.5 million individuals in Germany have diabetes. Approximately 2 million people are thought to have undiagnosed diabetes. Over the next 20 years, Germany's type 2 diabetes population will continue to increase. By 2040, up to twelve million people may have the metabolic disorder, according to DZD researchers.
Chronic wounds are thought to afflict 2.2 million individuals in the UK and cost the National Health Service (NHS) £5.3 billion annually. According to recent studies, nurses in the UK change the dressings on each patient's chronic wounds about 180 times annually. According to the poll, the typical patient with a chronic wound has been afflicted for more than eight months, and an estimated 300,000 individuals (11%) have been affected for more than a year. Most patients (80%) need their dressings changed at least twice a week, and more than one-third (35%) need them changed every day.
In September 2024, according to Chris Barry, executive vice president and group president, Medical Surgical, Solventum, the company is dedicated to resolving clinical issues and expanding access to care so that more patients can take advantage of V.A.C.® Therapy, one of the most researched and successful advanced wound treatments currently on the market.
By Product
By Application
By End Use
By Region
March 2025
March 2025
March 2025
February 2025
Schedule a Meeting